MONTE ROSA THERAPEUTICS INC (GLUE) Institutional Ownership Changes & 13F Activity
MONTE ROSA THERAPEUTICS INC (GLUE). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings. This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include Renaissance Technologies LLC.
| Portfolio quarter | Name | Type | Quantity | Remaining | Reported stock balance |
|---|---|---|---|---|---|
| Q1 2026 | Renaissance Technologies LLC | Sell | -16,633 | 379,100 | $6,236,195 |
| Q3 2025 | Renaissance Technologies LLC | Sell | -219,367 | 395,733 | $2,932,382 |
| Q2 2025 | Renaissance Technologies LLC | Buy | 451,000 | 615,100 | $2,774,101 |
| Q1 2025 | Renaissance Technologies LLC | Sell | -81,600 | 164,100 | $761,424 |
| Q4 2024 | Renaissance Technologies LLC | Buy | 27,000 | 245,700 | $1,705,158 |
| Q3 2024 | Renaissance Technologies LLC | Sell | -36,014 | 218,700 | $1,159,110 |
| Q2 2024 | Renaissance Technologies LLC | Buy | 132,614 | 254,714 | $952,630 |
| Q1 2024 | Renaissance Technologies LLC | Buy | 16,900 | 122,100 | $861 |
| Q4 2023 | Renaissance Technologies LLC | Buy | 13,700 | 105,200 | $594 |
| Q3 2023 | Renaissance Technologies LLC | Buy | 9,700 | 91,500 | $438 |
| Q2 2023 | Renaissance Technologies LLC | Buy | 53,900 | 81,800 | $560 |
| Q1 2023 | Renaissance Technologies LLC | Buy | 11,500 | 27,900 | $217 |
| Q4 2022 | Renaissance Technologies LLC | Buy | 16,400 | 16,400 | $125 |
Frequently asked questions about GLUE activity
Which institutional owners are buying GLUE?
Institutional owners buying GLUE include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in GLUE activity?
"Buy" means an investor increased their reported position in GLUE compared to the prior reporting period. This reflects growing exposure to MONTE ROSA THERAPEUTICS INC (GLUE) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in GLUE increasing?
Institutional interest in GLUE can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related GLUE Institutional Insights
- GLUE Institutional Ownership Overview
- GLUE Institutional Ownership & Insiders Activity
- GLUE Institutional Ownership & 13F Activity
- GLUE Top Institutional Shareholders
- GLUE Institutional Buying Activity
- GLUE Institutional Selling Activity
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- GLUE Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings